These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15818142)

  • 1. Tobramycin in the medical intensive care unit.
    Ellinoy BR; Matsuda K; Nguyen TM
    Crit Care Med; 2005 Apr; 33(4):919. PubMed ID: 15818142
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE; Bloxham DD; Thompson WL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tobramycin by inhalation].
    Taéron C
    Rev Infirm; 2006 Mar; (119):35-6. PubMed ID: 16625786
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal toxicity due to inhaled tobramycin in lung transplant recipients.
    Laporta R; Ussetti P; Carreño MC
    J Heart Lung Transplant; 2006 May; 25(5):608. PubMed ID: 16678043
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglycoside-induced reversible tubular dysfunction.
    Alexandridis G; Liberopoulos E; Elisaf M
    Pharmacology; 2003 Mar; 67(3):118-20. PubMed ID: 12571406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin dosing in cystic fibrosis.
    Smyth A; Touw D; Tan KH; Bertenshaw C; Stableforth D
    Lancet; 2005 May 21-27; 365(9473):1767-8. PubMed ID: 15910946
    [No Abstract]   [Full Text] [Related]  

  • 8. Gentamicin and tobramycin in patients with various infections--nephrotoxicity.
    Kahlmeter G; Hallberg T; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():47-52. PubMed ID: 659349
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.
    Sung L; Dupuis LL; Bliss B; Taddio A; Abdolell M; Allen U; Rolland M; Tong A; Taylor T; Doyle J
    J Natl Cancer Inst; 2003 Dec; 95(24):1869-77. PubMed ID: 14679156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycosides--engineering important patient-centered outcomes with antibiotics.
    Noble DW
    Crit Care Med; 2009 Oct; 37(10):2855-6. PubMed ID: 19865017
    [No Abstract]   [Full Text] [Related]  

  • 12. Single daily tobramycin dosing in cystic fibrosis: is it better for the patients or the bugs?
    Vandenbussche HL; Klepser ME
    Lancet; 2005 Feb 12-18; 365(9459):547-8. PubMed ID: 15708080
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative nephrotoxicities of gentamicin, netilmicin and tobramycin in the rat.
    Soberon L; Bowman RL; Pastoriza-Munoz E; Kaloyanides GJ
    J Pharmacol Exp Ther; 1979 Sep; 210(3):334-43. PubMed ID: 480186
    [No Abstract]   [Full Text] [Related]  

  • 14. Gentamicin v. Tobramycin.
    Drug Ther Bull; 1982 Feb; 20(3):11-2. PubMed ID: 7060464
    [No Abstract]   [Full Text] [Related]  

  • 15. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
    Smyth A; Tan KH; Hyman-Taylor P; Mulheran M; Lewis S; Stableforth D; Prof Knox A;
    Lancet; 2005 Feb 12-18; 365(9459):573-8. PubMed ID: 15708100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on drug therapy: IX. Gentamicin and tobramycin nephrotoxicity.
    Darr MS; Elenbaas JK
    J Am Med Womens Assoc (1972); 1981 Oct; 36(10):310-6. PubMed ID: 7346536
    [No Abstract]   [Full Text] [Related]  

  • 17. The absence of nephrotoxicity and differential nephrotoxicity between tobramycin and gentamicin.
    Kepczyk T; Ryan PJ; McAllister K; Otraje J
    South Med J; 1990 Oct; 83(10):1149-52. PubMed ID: 2218653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin nephrotoxicity. A prospective clinical study.
    Coca A; Blade J; Martinez A; Segura F; Soriano E; Ribas-Mundo M
    Postgrad Med J; 1979 Nov; 55(649):791-6. PubMed ID: 523366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin vs. tobramycin.
    Med Lett Drugs Ther; 1980 Oct; 22(20):85-6. PubMed ID: 7421726
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival.
    Oostdijk EA; de Smet AM; Bonten MJ;
    Am J Respir Crit Care Med; 2013 Jul; 188(1):117-20. PubMed ID: 23815730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.